Venous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding...
Keywords: Venöse Thrombose, Rezidiv, sekundäre Thromboseprophylaxe, Vitamin-K-Antagonisten, Risikofaktoren
01/2006 | Hämostaseologie, SchattauerHeparins and vitamin K antagonists have been the cornerstones of anticoagulation therapy for several decades...
Keywords: Antikoagulanzien, Faktor-Xa-Inhibitoren, Faktor-IIa-Inhibitoren, Vitamin-K-Antagonisten
01/2007 | Hämostaseologie, SchattauerVitamin K antagonists (VKA) are known to act as teratogens; however, there is still uncertainty about the relative risk for birth defects and the most sensitive period...
Keywords: pregnancy, coumarin derivatives, vitamin K antagonists, human, teratogenicity, spontaneous abortion
06/2006 | Thrombosis and Haemostasis, Schattauer